-
Human Identification Market by Product & Services (Instruments, Consumables, Software), Technology (NGS, PCR, Capillary Electrophoresis, Microarray), End User (Forensic Laboratories), Application (Paternity Testing, Forensic) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 26, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Neuroscience Antibodies & Assays Market by Technology (Immunoassay, Molecular Diagnostics), Product (Reagent (Enzymes, Media, Sera, Stain, Probe), Instruments), Application, End User (Hospital, Research Institute) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 26, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Animal Genetics Market by Products & Services (Live Animals (Canine, Poultry, Porcine, Bovine), Genetic Material (Semen, Embryo), Genetic Testing (DNA Testing, DNA Typing, Genetic Disease Testing)) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 26, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Gel Documentation Systems Market by End User (Academic Institutes, Biotechnology Companies), Product (Instruments, Software), Light Source (UV, Laser, LED), Detection (Chemiluminescence), Application (Nucleic Acid) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Genotyping Assay Market by Technology (Sequencing, PCR, Electrophoresis, Microarray, MALDI-TOF), Application (Diagnostic Research, Pharmacogenomics, Agricultural Biotechnology, Animal Genetics), and Product – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Biopreservation Market by Product (Sera, Media, Thawing Equipment, Cryogenic Storage Systems, Alarms), Application (Regenerative Medicine, Therapeutic, Clinical Trials), Biospecimen (Stem Cells, Human Tissue, Organs), End User – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Metagenomic Sequencing Market by Application (Soil Microbiome, Diagnostic), Workflow (Data Analysis, Sample Preparation), Product & Services (Consumables, Instruments, Reagents), Technology (Whole-Genome, Shotgun, 16s Rrna) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Vaccines Market by Technology (Recombinant, Toxoid, Conjugate, RNA), Type (Monovalent, Multivalent), Disease (Pneumococcal, Influenza, DTP, HPV, MMR, COVID-19), Route of Administration (IM, SC, Oral), End User (Pediatric, Adult) & Region – Global Forecast 2024 – 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Microcarrier Market by Microcarriers (Protein coated, Cationic, Collagen), Equipment (Filtration System, Bioreactor, Culture Vessels, Cell Counter), Consumables (Serum Free Media, Sera), Application (Cell Therapy, Vaccines) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Specimen Validity Testing Market by Type (POC Testing, Laboratory), Product (Assay Kits, Reagent, Controls, Disposables), End User (Pain Management, Workplace, Drug Screening, Drug Rehabilitation Centers) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Creatinine Assay Kits Market by Sample (Urine, Blood, Serum, Sweat, Saliva, CSF, Tissue Homogenate), Type (ELISA, Jaffe’s Kinetic Test, Creatinine-PAP), Region (Europe, North America, Asia and RoW) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 25, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Regenerative Medicine Market Size by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) & Region – Global Forecast 2024 – 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
3D Bioprinting Market by Technology (Inkjet, Microextrusion, Laser, Magnetic), Material (Extracellular Matrices, Cells, Hydrogels, Biomaterials), Application (Research (Regenerative Medicine) & Clinical (Cartilage, Bone, Skin)) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Reporter Gene Assay Market by Application (Protein Interaction, Gene Regulation, Cell Signalling Pathways), Reagents & Assay kits (Green Fluorescent Protein, Luciferase, â-glucuronidase, â-galactosidase), End Users, Region – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Hydrophobic Interaction Chromatography Market by Sample (Vaccines, Monoclonal Antibodies), Product & Services (Resin, Buffer, Columns (Prepacked, Empty)), End User (CROs & CMOs, Pharmaceutical Companies, Research Institutes) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Transfer Membrane Market by End user (Pharmaceutical Companies, Academia, Diagnolab), Type (Nylon, PVDF, Nitrocellulose), Transfer Method (Dry, Tank, Semi-dry), Application (Protein Sequencing, Western, Northern, Southern Blot) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Cell Analysis Market by End User (Research, Pharma, Biotechnology Companies), Product (Microscope, Spectrophotometers, Flow cytometry), Process (Cell Proliferation, Cell Viability, Signal Transduction) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Biochips Market Size & Share by End user (Diagnostics Centers, Academics Institutes), by Type (DNA Chip, Lab-on-a-chip, Protein Chips), Fabrication Technology (Microfluidics, Microarrays) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Dairy Herd Management Market by Application (Breeding, Feeding), Product (Software (Cloud-based, On-premise), Automated Systems (Sensors, Milking Parlours, Meters, Reproductive & Health, Cattle Management)), End user (Large Farms) – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page -
Next-generation Sequencing Market by Product (SEQUEL, NOVASEQ, NEXTSEQ, NANOPORE), Consumables, Bioinformatics, Technology (ION, SMRT), Services (DENOVO, EXOME, RNA), Application, End User, Region – 2024 to 2029
$3,850.00 – $5,850.00Published on: January 24, 2023Select options This product has multiple variants. The options may be chosen on the product page
The Biotechnology Industry is witnessing an increase in collaborative partnerships with a view to developing newer techniques. During its “green wave” period the industry produced a number of agricultural applications. During its “red wave”, there were a number of developments in the medical space to target disease prevention and management. In its “white wave”, industrial applications were at the forefront. A further rise in demand for therapeutics and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is expected to further fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalised medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Our reports provide application insights, technology insights, regional insights and competitive insights on biomaterials, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology. To know more about our offerings in the Biotechnology market analysis, contact us.
The Biotechnology Industry is witnessing an increase in collaborative partnerships with the primary view of developing newer and pathbreaking technology. The market is set to expand at 9.9 percent CAGR to hit USD 775 billion by 2024 mainly on account of increase in the incidence of chronic diseases such as diabetes and cancer, development of technology innovation and favorable government conditions. The ratio of chronic disease all around the globe is continuously increasing, which is analyzed to propel growth in the industry overall. According to recent data, the estimated number of people affected by the chronic disease will rise to 629 million by 2045. Approximately half of America’s population suffers from at least one chronic disease and this number is growing continuously. These statistics are expected to pave the way for opportunities in the biotechnology market.
The industry has experienced what is known as a ‘wave’ phenomenon. During its ‘green wave’ period the industry produced a number of agricultural applications. During its ‘red wave’, there were a number of developments in the medical space to target disease prevention and management. In its ‘white wave’, industrial applications were at the forefront. A further rise in demand for therapeutic and diagnostic solutions on principles of ‘red wave’, DNA sequencing, and recombinant technology is expected to propel huge growth. Prevention, management and cure of chronic diseases such as hepatitis B, cancer, HIV and childhood disorders is also expected to boost fuel growth. Optimized development of DNA technology is expected to serve this sector as a high impact-rendering growth driver. It is expected to encourage researchers and manufacturers to increase research and development initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer. Personalized medicine, biosimilars, bioinformatics, management of genomic data through studies on plants, animals and human genomes is also expected to drive segment growth during the forecast period.
Global Market Studies’ Biotechnology Market Research reports analysis provide application insights, technology insights, regional insights and competitive insights vis-a-vis the subsectors of biomaterials, biomanufacturing, genomics, proteomics, bioinformatics, biomarkers, biosimilars, drug delivery and discovery, stem cell, food and agriculture technology and tissue regeneration technology, among others. Key competitor analysis includes that of Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.
Contact us at Global Market Studies to know more about our offerings in the Biotechnology sector.